(Kuala Lumpur, 11th) Mahkota Housing $MBSB (1171.MY)$ announced yesterday the unexpected 2.75 cents per share interim dividend, some analysts believe that the bank may distribute an additional dividend between March and June 2025, increasing the total annual dividend to 3.5 cents per share.
The aforementioned 2.75 cents per share interim dividend will be ex-dividend on December 23 and paid out on January 6, 2025.
According to the local financial media "The Edge", Mahkota Housing used to announce dividends only in June of each year for the previous fiscal year.
BIMB Securities analyst pointed out that after the unexpected dividend yesterday, Mah Sing is expected to distribute dividends for the 2024 fiscal year totaling 3.5 sen per share, with the next dividend possibly falling in the next quarter of next year, while the weekly dividend yield is equivalent to 4.7%.
"We also believe that Mah Sing will maintain a full-year dividend of 3.5 sen in the 2025 and 2026 financial years."
In terms of performance prospects, the analyst remains cautious about the short-term outlook of Mah Sing, noting that the Banks needs to make more efforts to reduce its Gross Impaired Loans (GIL) ratio and drive its Return on Equity (ROE).
Currently, the analyst maintains profit expectations for Mah Sing, with net profit forecasts for the 2024 and 2025 financial years at 0.329 billion Ringgit and 0.480 billion Ringgit respectively.
Therefore, the analyst also maintains a "Hold" rating for Mah Sing Group, with the target price remaining at 80 cents.

Industrial Bank sets a Target Price of RM11.67 for Jinwuda, still having room for an increase.
Industrial Bank believes that Jinwuda $GAMUDA (5398.MY)$ will continue to have strong upside potential in the next 12 months, as its revenue performance is strong and it may win more new projects.
Industrial Bank analysts have raised Jinwuda's Target Price by 1.15 Ringgit to 11.67 Ringgit, this is the highest target price among the 21 securities firms tracking the stock, and maintain a 'Buy' rating.
At the same time, LC Securities has also raised Kinwahda's target price by 80 cents to 11.00 Ringgit.
CIB pointed out that Kinwahda may obtain more renewable Energy and Railroads projects in Australia, which were not fully considered before.
Currently, there are approximately 4 billion Australian Dollars (about 11.2 billion Ringgit) worth of renewable Energy projects in Australia, and Kinwahda has entered the list of candidates.
In addition, Kinwahda is also competing for the Eastern Suburbs Rail Loop project, with an expected share of about 3 billion Australian Dollars (about 8.4 billion Ringgit), and may also participate in the construction project of Sydney Metro West Line stations, with a value of up to 1.5 billion Australian Dollars (about 4.2 billion Ringgit).
Benefiting from the strong growth of the construction industry and optimistic sentiment regarding the progress of major infrastructure projects, KinWooDa's stock price has doubled so far this year, reaching a historic high.
Furthermore, several pieces of news about high-profit projects related to building datacenters have also driven the stock price up.
Despite the significant increase in stock price, analysts still maintain an optimistic attitude towards KinWooDa.
...

(Kuala Lumpur, 11th news) TMC Life Sciences' $TMCLIFE (0101.MY)$ former CEO Wan Nadia confirmed that she was removed from the position of CEO due to allegations of improper conduct, and stated that she will appeal against this decision.
In a statement on Tuesday, Wan Nadia said she had received a notification letter from the board informing her of her dismissal.
Just this Monday, at an extraordinary shareholder meeting convened by TMC Life Sciences regarding Wan Nadia's case, they approved the removal of her duties.
Wan Nadia said in a statement: "I would like to confirm that I have not been accused of any criminal behavior, criminal dishonesty, financial mismanagement, or integrity-related issues."
"In any case, I strongly deny all improper behavior allegations made against me by the company and will explore all possible ways to seek a fair resolution, including legal means."
TMC Life Sciences stated in a announcement on the Bursa Malaysia Exchange on Tuesday that the decision to remove Wan Nadia from her position was made after careful consideration of her years of service, performance record, mitigating circumstances, and the results of an independent internal investigation into the 5 allegations of improper conduct.
"These allegations involve issues arising from the termination of agreements with insurance companies and ICT engineering agreements."
During the investigation, Vanessa once counterattacked these accusations, claiming that the company tried to "blame" her for certain contract decisions.
The performance during the term is there for all to see.
Vanessa also said she was disappointed with the circumstances that led to her leaving the company.
"As a CEO, my performance is obvious...